On September 10, 2021, the Hangzhou Science and Technology Bureau announced the list of enterprises proposed to be recognized under the "Hangzhou 'Young Eagle Plan'". Among these 848 enterprises, Hangzhou Berisimo Biomedical Technology Co., Ltd. was included, becoming one of the key technology-based start-ups that Hangzhou is focusing on cultivating and supporting.